Semler Scientific (NASDAQ:SMLR) Trading Down 5.1% – Here’s Why

Semler Scientific, Inc. (NASDAQ:SMLR)’s stock price was down 5.1% during mid-day trading on Wednesday . The stock traded as low as $62.12 and last traded at $61.64. Approximately 53,241 shares were traded during trading, a decline of 86% from the average daily volume of 387,956 shares. The stock had previously closed at $64.94.

Semler Scientific Trading Down 3.9 %

The company has a market capitalization of $578.28 million, a price-to-earnings ratio of 30.61 and a beta of 1.18. The company has a 50-day moving average of $59.62 and a 200-day moving average of $39.83.

Semler Scientific (NASDAQ:SMLR) last posted its earnings results on Monday, November 4th. The company reported $0.72 EPS for the quarter, topping analysts’ consensus estimates of $0.37 by $0.35. The business had revenue of $13.51 million for the quarter. Semler Scientific had a return on equity of 20.31% and a net margin of 27.00%.

Institutional Investors Weigh In On Semler Scientific

A number of institutional investors have recently added to or reduced their stakes in SMLR. Rhumbline Advisers raised its position in shares of Semler Scientific by 27.1% during the 2nd quarter. Rhumbline Advisers now owns 6,197 shares of the company’s stock worth $213,000 after purchasing an additional 1,320 shares during the last quarter. Dimensional Fund Advisors LP raised its holdings in Semler Scientific by 18.3% in the 2nd quarter. Dimensional Fund Advisors LP now owns 126,177 shares of the company’s stock valued at $4,341,000 after acquiring an additional 19,552 shares during the last quarter. AQR Capital Management LLC raised its holdings in Semler Scientific by 150.1% in the 2nd quarter. AQR Capital Management LLC now owns 140,498 shares of the company’s stock valued at $4,833,000 after acquiring an additional 84,314 shares during the last quarter. Newbridge Financial Services Group Inc. acquired a new stake in shares of Semler Scientific during the 2nd quarter worth $34,000. Finally, Shariaportfolio Inc. acquired a new stake in shares of Semler Scientific during the 3rd quarter worth $3,618,000. Hedge funds and other institutional investors own 49.37% of the company’s stock.

Semler Scientific Company Profile

Semler Scientific, Inc provides technology solutions to enhance the clinical effectiveness and efficiency of healthcare providers in the United States. The company’s products include QuantaFlo, a four-minute in-office blood flow test that enables healthcare providers to use blood flow measurements as part of their examinations of a patient’s vascular condition.